Epidermal Nerve Fiber Density (ENFD) will be suggested before initiating our treatment protocol to measure the before and after effects of our plan of care. Nerve recovery is slow and often times confusing to our patients. Long dormant nerves will slowly and steadily come back to life but the brain pathways required to interpret this new sensory input may confused feeling something for feeling something painful for the fiorst time in many years. Since we cannot see the nerves like a blemish on our face we rely again on technological advances to allow us to see...and then individually count the nerves on your foot.

Independent laboratory test results conclusively demonstrate dramatic increases in nerve fiber density following treatment with our multi-faceted, FDA-approved and proven protocols: Aspen Class IV laser, Extracorporal Shockwave Therapy, Amniotic Stem Cell injections and Neurogenx NervePro 2.0.

Epidermal Nerve Fiber Density (ENFD) tests show:

• Average increase of 165.4% in nerve fiber density, with
• Some patients having increases as high as 395%.
• ENFD testing is the gold standard in diagnosing and monitoring small fiber peripheral neuropathy (the type of neuropathy responsible for pain, burning and numbness.)
• Other routine tests, such as EMG and nerve conduction studies, are often normal in patients with small fiber neuropathy.
• ENFD testing is also important because it allows clinicians to objectively monitor a patients’ improvement in response to treatment.
• A picture is worth 1,000 words